BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33007364)

  • 1. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
    Ma L; Wang Y; Chen X; Zhao L; Guo Y
    Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
    Bai X; Hong W; Cai P; Chen Y; Xu C; Cao D; Yu W; Zhao Z; Huang M; Jin J
    Toxicol Appl Pharmacol; 2017 Jun; 324():12-25. PubMed ID: 28366540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trivalent chromium alleviates oleic acid induced steatosisĀ in SMMC-7721 cells by decreasing fatty acid uptake and triglyceride synthesis.
    Wang S; Wang J; Zhang X; Hu L; Fang Z; Huang Z; Shi P
    Biometals; 2016 Oct; 29(5):881-92. PubMed ID: 27497686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Valproic Acid-Enhanced Hepatocyte Steatosis.
    Chang R; Chou MC; Hung LY; Wang ME; Hsu MC; Chiu CH
    Biomed Res Int; 2016; 2016():9576503. PubMed ID: 27034954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics attenuate valproate-induced liver steatosis and oxidative stress in mice.
    Song W; Yan X; Zhai Y; Ren J; Wu T; Guo H; Song Y; Li X; Guo Y
    PLoS One; 2023; 18(11):e0294363. PubMed ID: 37971986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obeticholic Acid Ameliorates Valproic Acid-Induced Hepatic Steatosis and Oxidative Stress.
    Gai Z; Krajnc E; Samodelov SL; Visentin M; Kullak-Ublick GA
    Mol Pharmacol; 2020 May; 97(5):314-323. PubMed ID: 32098797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
    Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
    Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol metabolism by alcohol dehydrogenase or cytochrome P
    Doody EE; Groebner JL; Walker JR; Frizol BM; Tuma DJ; Fernandez DJ; Tuma PL
    Am J Physiol Gastrointest Liver Physiol; 2017 Dec; 313(6):G558-G569. PubMed ID: 28864499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
    Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
    Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of ER stress and P450 2E1 in CCl(4)-induced steatosis.
    Lee GH; Bhandary B; Lee EM; Park JK; Jeong KS; Kim IK; Kim HR; Chae HJ
    Int J Biochem Cell Biol; 2011 Oct; 43(10):1469-82. PubMed ID: 21722752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance.
    Choi CS; Savage DB; Kulkarni A; Yu XX; Liu ZX; Morino K; Kim S; Distefano A; Samuel VT; Neschen S; Zhang D; Wang A; Zhang XM; Kahn M; Cline GW; Pandey SK; Geisler JG; Bhanot S; Monia BP; Shulman GI
    J Biol Chem; 2007 Aug; 282(31):22678-88. PubMed ID: 17526931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
    Ganji SH; Kashyap ML; Kamanna VS
    Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
    Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
    Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD36 and DGAT2 facilitate the lipid-lowering effect of chitooligosaccharides
    Shen X; Liang X; Ji X; You J; Zhuang X; Song Y; Yin H; Zhao M; Zhao L
    Food Funct; 2021 Sep; 12(18):8681-8693. PubMed ID: 34351342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach on valproic acid induced hepatotoxicity: involvement of lysosomal membrane leakiness and cellular proteolysis.
    Pourahmad J; Eskandari MR; Kaghazi A; Shaki F; Shahraki J; Fard JK
    Toxicol In Vitro; 2012 Jun; 26(4):545-51. PubMed ID: 22342442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice.
    Yu XX; Murray SF; Pandey SK; Booten SL; Bao D; Song XZ; Kelly S; Chen S; McKay R; Monia BP; Bhanot S
    Hepatology; 2005 Aug; 42(2):362-71. PubMed ID: 16001399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
    Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
    Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kitano A; Norikura T; Matsui-Yuasa I; Shimakawa H; Kamezawa M; Kojima-Yuasa A
    J Med Food; 2022 Oct; 25(10):982-992. PubMed ID: 36201260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease.
    Tsedensodnom O; Vacaru AM; Howarth DL; Yin C; Sadler KC
    Dis Model Mech; 2013 Sep; 6(5):1213-26. PubMed ID: 23798569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.